Specifically, DDX27 facilitates hepatocellular carcinoma progression via activating ERK signaling (Xiaoqian et al., 2021), and enhances stem cell-like features with undesirable survival outcome of breast cancer (Li S. et al., 2021) and colorectal cancer (Yang et al., 2019). Here, DDX27 is linked to hepatocellular carcinoma.